In humans, the GLP-1 receptor is expressed in the pancreas, lungs, brain, kidneys, stomach, and heart but not in the liver, skeletal muscle, or adipose tissue [27]
Importantly, these effects persist throughout long-term treatment, avoiding the tolerance development and efficacy loss observed with some appetite suppressants
This article explores what each compound does, how they function in the body, and whether a dual approach aligns with evidence-based practice
Adopting Narrative Inquiry as a methodology, this study explores the stories constructed by three young people with ME/CFS, aged between sixteen and seventeen, in relation to their school experiences